COVID-19 Vaccines Webinar
Due to unforeseen circumstances, a change has been made to the speaker list for the upcoming COVID-19 Vaccines webinar on 22 February 2021.
However, we are delighted to welcome Dr Kelly Lindert to the programme.
Dr. Kelly Lindert is the Senior Vice President of Clinical Development, Vaccines at Arcturus Therapeutics, where she leads the clinical development of the ARCT-021, a vaccine candidate designed to address SARS-CoV-2. She has previously worked at Moderna and Novartis Vaccines. At the latter she was responsible for the US approvals of Fluad (adjuvanted influenza vaccine), Flucelvax quadrivalent (cell based influenza vaccine), and contributed to global pandemic influenza vaccines to address A/H1N1 2009 and A/H5N1 and the development of multiple additional vaccines in the portfolio. Her medical training included an M.D. degree at University of Chicago and residency training at Stanford University.
February 19th-2021
